📰 Maxs Topp News

Maxs Topp News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Maxs Topp. Real-time updates on events, politics, business and more.

KITE'S CAR T-CELL THERAPY TECARTUS® (BREXUCABTAGENE AUTOLEUCEL) GRANTED EUROPEAN MARKETING AUTHORISATION FOR THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKAEMIA (r/r ALL)

September 7, 2022

KITE&rsquo;S&nbsp; CAR&nbsp; T-CELL&nbsp; THERAPY&nbsp; TECARTUS&reg;&nbsp; (BREXUCABTAGENE&nbsp; AUTOLEUCEL)&nbsp; GRANTED EUROPEAN MARKETING AUTHORISATION FOR THE TREATMENT OF&nbsp; RELAPSED&nbsp; OR&nbsp; REFRACTORY&nbsp; ACUTE&nbsp; LYMPHOBLASTIC&nbsp; LEUKAEMIA&nbsp; (r/r ALL)&nbsp;-- Approval Marks Kite&rsquo;...

United States Santa Monica United Kingdom Foster City Christi Shaw Brexucabtagene Autoleucel

Source: pharmiweb.com

Gilead Sciences, Inc.: Kite's CAR T-cell Therapy Tecartus Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (r/r ALL)

September 6, 2022

-- Approval Marks Kite's Fourth Indication in Europe for its Two Cell Therapies and First in Leukemia -- -- Overall Complete Remission of 71% and a Median Overall Survival of More Than Two Years

United States Santa Monica Foster City Christi Shaw Jacquie Ross Maxs Topp

Source: finanznachrichten.de

Kite's CAR T-cell Therapy Tecartus Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (r/r ALL) Seite 1

September 6, 2022

07.09.2022 - Kite, a Gilead Company (Nasdaq: GILD), today announced that the European Commission (EC) has approved its CAR T-cell therapy Tecartus (brexucabtagene autoleucel) for the treatment of adult patients 26 years of age and above with relapsed or ... Seite 1

Maxs Topp University Hospital Of Wuerzburg University Hospital Gilead Sciences

Source: wallstreet-online.de

KITE'S CAR T-CELL THERAPY TECARTUS® (BREXUCABTAGENE AUTOLEUCEL) RECEIVES POSITIVE CHMP OPINION IN RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKAEMIA (r/r ALL)

July 22, 2022

KITE&rsquo;S&nbsp; CAR&nbsp; T-CELL&nbsp; THERAPY&nbsp; TECARTUS&reg;&nbsp; (BREXUCABTAGENE&nbsp; AUTOLEUCEL)&nbsp; RECEIVES&nbsp; POSITIVE&nbsp; CHMP&nbsp; OPINION&nbsp; IN&nbsp; RELAPSED&nbsp; OR&nbsp; REFRACTORY&nbsp; ACUTE&nbsp; LYMPHOBLASTIC&nbsp; LEUKAEMIA&nbsp; (r/r ALL)&nbsp;&ndash;&nbsp; Tecartus&reg; (Brex...

United States Santa Monica United Kingdom Foster City Christi Shaw Brexucabtagene Autoleucel

Source: pharmiweb.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation